These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6203492)

  • 21. Hydatidiform moles.
    Heath JM; Bu TH; Brereton WF
    Am Fam Physician; 1985 May; 31(5):123-31. PubMed ID: 2581433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial hydatidiform mole in the fallopian tube.
    Terada S; Suzuki N; Uchide K; Akasofu K
    Gynecol Obstet Invest; 1993; 35(4):240-2. PubMed ID: 7687230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Destructive bladder mole--follow-up by human chorionic gonadotropin (HCG), ultrasound and digital subtraction angiography (DSA)].
    Rehbock J; Ziegler L; Schramm T; Maassen V
    Geburtshilfe Frauenheilkd; 1990 Nov; 50(11):893-5. PubMed ID: 2283017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemistry of molar and non-molar placentas with special reference to their differential diagnosis.
    Fukunaga M; Miyazawa Y; Sugishita M; Ushigome S
    Acta Pathol Jpn; 1993 Nov; 43(11):683-9. PubMed ID: 7508673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple metastatic gestational trophoblastic disease after a twin pregnancy with complete hydatidiform mole and coexisting fetus, following assisted reproductive technology: Case report and literature review.
    Nobuhara I; Harada N; Haruta N; Higashiura Y; Watanabe H; Watanabe S; Hisanaga H; Sado T
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):588-593. PubMed ID: 30122584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
    Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
    Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent partial molar pregnancy. A report of uterus-preserving treatment and follow-up with magnetic resonance imaging.
    Wright-Browne V; Kudelka AP; Malpica A; Edwards CL; Varma DG; Kavanagh JJ
    Am J Clin Oncol; 1996 Oct; 19(5):534-9. PubMed ID: 8823486
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy for gestational trophoblastic tumors.
    Takamizawa H; Sekiya S; Kobayashi O; Matsui H
    Semin Surg Oncol; 1987; 3(1):36-44. PubMed ID: 3027827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrepancy in the diagnoses of hydatidiform mole by macroscopic and microscopic findings and the deoxyribonucleic acid fingerprint method.
    Takahashi H; Kanazawa K; Ikarashi T; Sudo N; Tanaka K
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 1):112-3. PubMed ID: 2375332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetically Related Choriocarcinoma Developing 5 Yr After a Complete Hydatidiform Mole and Simulating a Cornual Ectopic Pregnancy.
    Chau DB; Beavis AL; Ronnett BM; Jenson E; Gocke CD; Anderson J; Nickles Fader A; Stone R
    Int J Gynecol Pathol; 2020 Jul; 39(4):367-372. PubMed ID: 31033803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
    Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent partial hydatidiform mole: a report of a patient with three consecutive molar pregnancies.
    Koc S; Ozdegirmenci O; Tulunay G; Ozgul N; Kose MF; Bulbul D
    Int J Gynecol Cancer; 2006; 16(2):940-3. PubMed ID: 16681793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on molar pregnancy and choriocarcinoma.
    Ilancheran A; Singh P
    Singapore Med J; 1989 Oct; 30(5):473-5. PubMed ID: 2694375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hysteroscopy in the diagnosis and treatment of residua after evacuation of hydatidiform mole].
    Wilczak M; Sajdak S; Woźniak J; Cwojdziński M; Nowak-Markwitz E; Pisarski T
    Ginekol Pol; 1994 Sep; 65(9):522-6. PubMed ID: 7536698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydatidiform mole with non-metastatic pulmonary complications and a false low level of hCG.
    Flam F; Hambraeus-Jonzon K; Hansson LO; Kjaeldgaard A
    Eur J Obstet Gynecol Reprod Biol; 1998 Apr; 77(2):235-7. PubMed ID: 9578284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.